-
Aug 10, 2023, 09:23 AM
by
Phastar Appoints Graham Clark as New Chief Executive Officer
Phastar Sets Course for Further Growth with New CEO Appointment
Full story
-
Aug 10, 2023, 09:23 AM
by
Healthcare chatbots are set to change how we look after our health. In the future, these digital helpers will talk more like humans, making it feel like chatting with a friend. They'll learn from each conversation, offering better advice over time. These chatbots will work alongside doctors, helping screen and understand patients' problems. They'll speak many languages, team up with gadgets like smartwatches to monitor our health, and be available 24/7. Plus, they'll remind us about medicines and appointments, keep our health data safe, and even help with emotional well-being. In short, they'll make healthcare more personal, easy, and accessible for everyone.
Full story
-
Aug 9, 2023, 16:53 PM
by
User Not Found
Bio-IT World | Illumina today announced that Alex Aravanis, CTO, has departed Illumina to pursue an opportunity outside of the company effective immediately. In his place, Steven Barnard, Illumina's Vice President and Head of Global Advanced Science, will serve as its next Chief Technology Officer (CTO).
Full story
-
Aug 9, 2023, 09:03 AM
by
Full story
-
Aug 9, 2023, 09:03 AM
by
VectorBuilder's latest cash injection drives them towards a CDMO facility for the manufacturing of plasmids, mRNA, AAV, lentivirus, cell lines, and a variety of viral and non-viral vectors
Full story
-
Aug 9, 2023, 09:03 AM
by
ArisGlobal's move to the Greater Boston area reflects growth needs and geographically positions the life sciences SaaS provider among leading biopharmaceutical organizations.
Full story
-
Aug 9, 2023, 09:03 AM
by
About Huateng Pharma
Huateng Pharma is a global provider in contract development and manufacturing for intermediates. With our focus on operational excellence, and the integration of manufacturing operations with EHS, quality assurance, quality control, regulatory, supply chain management and project management, we can manufacture, scale-up and supply high-quality intermediates and APIs from our China facility.
Contact us
Hunan Huateng Pharmaceutical Co. Ltd.
Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China
Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China
Email: sales@huatengusa.com
Website: https://us.huatengsci.com
Zip code: 410205
Telephone: +86 731 89916275
Fax: +86 0731-82251112-818
Full story
-
Aug 9, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Carenostics is a healthcare AI startup founded with the mission of addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and ML on existing healthcare data.
Full story
-
Aug 8, 2023, 01:00 AM
by
User Not Found
Bio-IT World | “Generate Biomedicines’ goal of leveraging machine-learning powered generative biology to discover and develop new drugs faster and cheaper is supported by an integrated and cohesive R&D data platform… FAIR to its core, this integrated data platform leverages industry best practices and lessons-learned from a talented team of informatics engineers to form the critical foundation of a unique company with equal parts ‘bio’ and ‘tech’.”
Full story
-
Aug 3, 2023, 10:02 AM
by
Full story
-
Aug 3, 2023, 09:29 AM
by
The Lactocore Group has joined BioLabs Heidelberg, marking a significant expansion in the European Union of innovative research and development in the field of peptide therapy for the treatment of depression, anxiety and metabolic disorders.
Full story
-
Aug 3, 2023, 09:29 AM
by
Full story
-
Aug 3, 2023, 01:00 AM
by
User Not Found
Bio-IT World | The prognosis of lung carcinoma has changed since the discovery of molecular targets and their specific drugs. Somatic EGFR mutations have been reported in lung carcinoma, and these mutant proteins act as substrates for targeted therapies.
Full story
-
Aug 2, 2023, 09:05 AM
by
Leading integrated drug discovery partner, Sygnature Discovery (“Sygnature”) has announced its acquisition of one of North America’s largest discovery Contract Research Organisations, Canada-based NuChem Sciences. This acquisition cements Sygnature as one of the world’s largest players in integrated drug discovery phase solutions and advances their vision to become the global market leader.
Full story
-
Aug 2, 2023, 09:05 AM
by
Titian Software LTD and Evotec have signed a 3-year agreement to expand their collaboration around Titian Software’s Mosaic Sample Management Platform.
Full story
-
Aug 2, 2023, 09:05 AM
by
Expert Speaker Lineup Revealed for Award Winning RBQM Event
Full agenda and keynote speakers announced for industry-leading risk-based quality management event focusing on the global transformation and evolution of RBQM, sponsored by CluePoints.
Full story
-
Aug 2, 2023, 09:05 AM
by
Scientists attend national patient retreat and share scientific updates on investigational EMD-101 for severe congenital neutropenia treatment
Full story
-
Aug 2, 2023, 09:05 AM
by
DNAnexus announced a collaboration with BigOmics Analytics to provide customers with a fully integrated solution to better understand large-scale proteomics and transcriptomics data.
Full story
-
Aug 2, 2023, 09:05 AM
by
The Portrait Project gives clinical trial patients a platform to share their unique experiences and influence change
Clinical trial participants, caregivers and health professionals share unfiltered accounts of their personal health journeys and provide insights into their experience in clinical trials.
Full story
-
Aug 2, 2023, 01:00 AM
by
User Not Found
Bio-IT World | The field of drug discovery is shifting its approach from viewing complex biology as something to be overcome using reductionist principles to something to embrace in a more holistic approach to cell biology.
Full story